Cornerstone Pharmaceuticals has received the US Food and Drug Administration (FDA) orphan drug designation for its altered energy metabolism directed (AEMD) drug candidate 'CPI-613' for treatment of myelodysplastic syndrome (MDS). MDS is ...
A multiple-sclerosis drug that was at the center of Sanofi SA's SAN.FR +1.12% $20 billion takeover battle for Genzyme Corp. three years ago was approved for sale in Europe on Tuesday, the drug's first regulatory approval world-wide. The ...
The US Food and Drug Administration (FDA) has approved breakthrough therapy designation for Danish biotechnology company Genmab and British pharmaceutical company GlaxoSmithKline’s (GSK) Arzerra (ofatumumab) in combination with ...
Tags: therapy designation, Medicine
Clinical-stage biopharmaceutical company Pharmacyclics' new drug application (NDA) for the investigational oral Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib, has been accepted by the US FDA for two B-cell malignancy indications. ...
Tags: Solvay Group, Medicine
SynGen has received 510(k) approval from the US Food and Drug Administration (FDA) to market its SynGenX-1000 System, CryoPRO-2 Cryopreservation/Storage Bag Set, SynGen DataTrak software products to process cord blood. Previously, the ...
Tags: Cord Blood Processing, Syngen
Janssen Research & Development is seeking FDA approval for use of ibrutinib in the treatment of previously treated patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL), and mantle cell lymphoma (MCL). The ...
Tags: FDA Approval, Janssen
Genentech, a member of the Roche Group, has obtained FDA priority review status for Obinutuzumab (GA101) to treat previously untreated chronic lymphocytic leukemia (CLL). The FDA has also accepted the company's biologics license ...
Tags: Genentech, FDA Priority
Stemline Therapeutics' SL-401 has won orphan drug designation from the Food and Drug Administration (FDA) for the treatment of aggressive hematologic malignancy blastic plasmacytoid dendritic cell neoplasm (BPDCN). With an orphan drug ...
Tags: Stemline Therapeutic, Orphan Drug
KNOXVILLE, Tenn., June 6, 2013 /PRNewswire-iReach/ -- On Saturday, June 15th the Knoxville, TN Stanton Optical store is having a customer appreciation celebration from Noon until 3:00 PM. General Manager Juan Jonny Lopez and Sales Manager ...
SAP abruptly reorganized its development strategy, with SuccessFactors CEO and cloud strategy chief Lars Dalgaard leaving the company and executive board member Vishal Sikka tapped to lead a single software development unit. Sikka has ...
Tags: Computer Products, software
The Canadian Nuclear Safety Commission (CNSC) says it has completed a “ground-breaking” study on populations living near Ontario’s three nuclear power plants (NPPs), which finds “no evidence of childhood leukemia ...
In the spirit of increasing awareness of the benefits of modern cloth diapers, Cutie Poops and Bottoms of Orland Park is helping children fighting cancer. The store recently participated in a worldwide event called The Great Cloth Diaper ...
Tags: Toys
If you've ever had trouble affording your medications and wanted to call your doctor on it, here's some encouraging news: Doctors aren't pleased about the prices either. Denouncing "profiteering" by pharmaceutical companies, more than 100 ...
Students at four District #210 Lincoln-Way high schools are participating in a program designed to make their local community a better environment in which to live, work and learn. T.E.A.M. Asset, an acronym for Teaching Everyone Assets ...
Tags: toys, toy industry
What is a Carcinogen? A carcinogen is any substance that can directly cause cancer in living tissue. Radioactive substances are considered to be carcinogens, as well as none -radioactive carcinogens, which include tobacco smoke, dioxins, ...